These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17485241)

  • 1. Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature.
    Brandt C; Fueratsch N; Boehme V; Kramme C; Pieridou M; Villagran A; Woermann F; Pohlmann-Eden B
    Epilepsy Behav; 2007 Aug; 11(1):133-9. PubMed ID: 17485241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hallucinosis using lamotrigine].
    Huber B; Hilgemann C
    Nervenarzt; 2009 Feb; 80(2):202-3. PubMed ID: 19189076
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels.
    Fröscher W; Keller F; Vogt H; Krämer G
    Epileptic Disord; 2002 Mar; 4(1):49-56. PubMed ID: 11967180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study.
    Aurlien D; Larsen JP; Gjerstad L; Taubøll E
    Epilepsia; 2012 Feb; 53(2):258-66. PubMed ID: 22126371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
    Kim JY; Lee HW
    Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-of-dose emergent psychopathology in ambulatory patients with epilepsy on stable-dose lamotrigine monotherapy: a case series of six patients.
    Frey LC; Strom LA; Shrestha A; Spitz MC
    Epilepsy Behav; 2009 Aug; 15(4):521-3. PubMed ID: 19643671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine in childhood epilepsies.
    Dreifuss FE
    Semin Pediatr Neurol; 1997 Mar; 4(1):19-23. PubMed ID: 9097363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine in idiopathic epilepsy - increased risk of cardiac death?
    Aurlien D; Taubøll E; Gjerstad L
    Acta Neurol Scand; 2007 Mar; 115(3):199-203. PubMed ID: 17295716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
    Tompson DJ; Ali I; Oliver-Willwong R; Job S; Zhu L; Lemme F; Hammer AE; Vuong A; Messenheimer JA
    Epilepsia; 2008 Mar; 49(3):410-7. PubMed ID: 17825077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-release lamotrigine in the treatment of patients with epilepsy.
    Syed TU; Sajatovic M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1579-85. PubMed ID: 20482306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine treatment of a patient affected by epilepsy and anxiety disorder.
    Sepić-Grahovac D; Grahovac T; Ružić-Baršić A; Ružić K; Dadić-Hero E
    Psychiatr Danub; 2011 Mar; 23(1):111-3. PubMed ID: 21448112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in patients with newly diagnosed epilepsy predicts lamotrigine-induced rash: a short-term observational study.
    Park SP
    Epilepsy Behav; 2013 Jul; 28(1):88-90. PubMed ID: 23673289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.